184 related articles for article (PubMed ID: 31504219)
1. Impaired D2 receptor-dependent dopaminergic transmission in prefrontal cortex of awake mouse model of Parkinson's disease.
Li M; Xu H; Chen G; Sun S; Wang Q; Liu B; Wu X; Zhou L; Chai Z; Sun X; Lu Y; Younus M; Zheng L; Zhu F; Jia H; Chen X; Wang C; Zhou Z
Brain; 2019 Oct; 142(10):3099-3115. PubMed ID: 31504219
[TBL] [Abstract][Full Text] [Related]
2. Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1.
Goldberg MS; Pisani A; Haburcak M; Vortherms TA; Kitada T; Costa C; Tong Y; Martella G; Tscherter A; Martins A; Bernardi G; Roth BL; Pothos EN; Calabresi P; Shen J
Neuron; 2005 Feb; 45(4):489-96. PubMed ID: 15721235
[TBL] [Abstract][Full Text] [Related]
3. Generation of an induced pluripotent stem cell line (GIBHi004-A) from a Parkinson's disease patient with mutant DJ-1/PARK7 (p.L10P).
Li Y; Ibañez DP; Fan W; Zhao P; Chen S; Md Abdul M; Jiang Y; Fu L; Luo Z; Liu Z; Yang Y; Guo J; Volpe G; Kanwal S; Wang D; Tang B; Li W
Stem Cell Res; 2020 Jul; 46():101845. PubMed ID: 32534165
[TBL] [Abstract][Full Text] [Related]
4. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
Sharma N; Rao SP; Kalivendi SV
Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
[TBL] [Abstract][Full Text] [Related]
5. Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice.
Luo Z; Ahlers-Dannen KE; Spicer MM; Yang J; Alberico S; Stevens HE; Narayanan NS; Fisher RA
JCI Insight; 2019 May; 5(13):. PubMed ID: 31120439
[TBL] [Abstract][Full Text] [Related]
6. Basal and Evoked Neurotransmitter Levels in Parkin, DJ-1, PINK1 and LRRK2 Knockout Rat Striatum.
Creed RB; Menalled L; Casey B; Dave KD; Janssens HB; Veinbergs I; van der Hart M; Rassoulpour A; Goldberg MS
Neuroscience; 2019 Jun; 409():169-179. PubMed ID: 31029729
[TBL] [Abstract][Full Text] [Related]
7. Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease.
Martella G; Madeo G; Schirinzi T; Tassone A; Sciamanna G; Spadoni F; Stefani A; Shen J; Pisani A; Bonsi P
Neuroscience; 2011 Mar; 177():240-51. PubMed ID: 21195752
[TBL] [Abstract][Full Text] [Related]
8. Delta oscillations are a robust biomarker of dopamine depletion severity and motor dysfunction in awake mice.
Whalen TC; Willard AM; Rubin JE; Gittis AH
J Neurophysiol; 2020 Aug; 124(2):312-329. PubMed ID: 32579421
[TBL] [Abstract][Full Text] [Related]
9. Characterization of striatum-mediated behavior and neurochemistry in the DJ-1 knock-out rat model of Parkinson's disease.
Giangrasso DM; Furlong TM; Keefe KA
Neurobiol Dis; 2020 Feb; 134():104673. PubMed ID: 31734455
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of DJ-1/PARK7-Mediated Parkinson's Disease.
Skou LD; Johansen SK; Okarmus J; Meyer M
Cells; 2024 Feb; 13(4):. PubMed ID: 38391909
[TBL] [Abstract][Full Text] [Related]
11. Loss of DJ-1 function contributes to Parkinson's disease pathogenesis in mice via RACK1-mediated PKC activation and MAO-B upregulation.
Liu LL; Han Y; Zhang ZJ; Wang YQ; Hu YW; Kaznacheyeva E; Ding JQ; Guo DK; Wang GH; Li B; Ren HG
Acta Pharmacol Sin; 2023 Oct; 44(10):1948-1961. PubMed ID: 37225849
[TBL] [Abstract][Full Text] [Related]
12. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease.
Bandopadhyay R; Kingsbury AE; Cookson MR; Reid AR; Evans IM; Hope AD; Pittman AM; Lashley T; Canet-Aviles R; Miller DW; McLendon C; Strand C; Leonard AJ; Abou-Sleiman PM; Healy DG; Ariga H; Wood NW; de Silva R; Revesz T; Hardy JA; Lees AJ
Brain; 2004 Feb; 127(Pt 2):420-30. PubMed ID: 14662519
[TBL] [Abstract][Full Text] [Related]
13. Progressively disrupted somatodendritic morphology in dopamine neurons in a mouse Parkinson's model.
Lynch WB; Tschumi CW; Sharpe AL; Branch SY; Chen C; Ge G; Li S; Beckstead MJ
Mov Disord; 2018 Dec; 33(12):1928-1937. PubMed ID: 30440089
[TBL] [Abstract][Full Text] [Related]
14. Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.
Inden M; Kitamura Y; Takahashi K; Takata K; Ito N; Niwa R; Funayama R; Nishimura K; Taniguchi T; Honda T; Taira T; Ariga H
J Pharmacol Sci; 2011; 117(3):189-203. PubMed ID: 22041943
[TBL] [Abstract][Full Text] [Related]
15. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease.
Burbulla LF; Song P; Mazzulli JR; Zampese E; Wong YC; Jeon S; Santos DP; Blanz J; Obermaier CD; Strojny C; Savas JN; Kiskinis E; Zhuang X; Krüger R; Surmeier DJ; Krainc D
Science; 2017 Sep; 357(6357):1255-1261. PubMed ID: 28882997
[TBL] [Abstract][Full Text] [Related]
16. Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease.
Frahm S; Melis V; Horsley D; Rickard JE; Riedel G; Fadda P; Scherma M; Harrington CR; Wischik CM; Theuring F; Schwab K
Behav Brain Res; 2018 Feb; 339():153-168. PubMed ID: 29180135
[TBL] [Abstract][Full Text] [Related]
17. Altered Expression of D1 and D2 Dopamine Receptors in Vagal Neurons Innervating the Gastric Muscularis Externa in a Parkinson's Disease Rat Model.
Wang ZY; Lian H; Zhou L; Zhang YM; Cai QQ; Zheng LF; Zhu JX
J Parkinsons Dis; 2016 May; 6(2):317-23. PubMed ID: 27164043
[TBL] [Abstract][Full Text] [Related]
18. Compensatory T-type Ca2+ channel activity alters D2-autoreceptor responses of Substantia nigra dopamine neurons from Cav1.3 L-type Ca2+ channel KO mice.
Poetschke C; Dragicevic E; Duda J; Benkert J; Dougalis A; DeZio R; Snutch TP; Striessnig J; Liss B
Sci Rep; 2015 Sep; 5():13688. PubMed ID: 26381090
[TBL] [Abstract][Full Text] [Related]
19. Genetic mutations linked to Parkinson's disease differentially control nucleolar activity in pre-symptomatic mouse models.
Evsyukov V; Domanskyi A; Bierhoff H; Gispert S; Mustafa R; Schlaudraff F; Liss B; Parlato R
Dis Model Mech; 2017 May; 10(5):633-643. PubMed ID: 28360124
[TBL] [Abstract][Full Text] [Related]
20. Conditional deletion of Ndufs4 in dopaminergic neurons promotes Parkinson's disease-like non-motor symptoms without loss of dopamine neurons.
Choi WS; Kim HW; Tronche F; Palmiter RD; Storm DR; Xia Z
Sci Rep; 2017 Mar; 7():44989. PubMed ID: 28327638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]